Northern Trust Corp Trims Stock Position in Cognex Corporation $CGNX

Key Points

• Northern Trust Corp reduced its stake in Cognex Corporation by 3.3% to approximately 1.00%, owning 1,684,305 shares valued at $50.24 million as of the first quarter.
• Cognex reported a quarterly earnings per share of $0.25, surpassing estimates and showing a 4.2% revenue increase year-over-year, with guidance for Q3 2025 set between $0.240-0.290 EPS.
• The company declared a quarterly dividend of $0.08, resulting in an annualized yield of 0.7% and a dividend payout ratio of 45.07%.

Northern Trust Corp cut its stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 3.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,684,305 shares of the scientific and technical instruments company's stock after selling 56,891 shares during the period. Northern Trust Corp owned approximately 1.00% of Cognex worth $50,243,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CGNX. First Trust Advisors LP raised its stake in Cognex by 18.5% during the 4th quarter. First Trust Advisors LP now owns 89,544 shares of the scientific and technical instruments company's stock valued at $3,211,000 after acquiring an additional 13,951 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Cognex by 6.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,902,930 shares of the scientific and technical instruments company's stock valued at $68,239,000 after acquiring an additional 117,089 shares during the last quarter. Stifel Financial Corp raised its stake in Cognex by 39.7% during the 4th quarter. Stifel Financial Corp now owns 99,197 shares of the scientific and technical instruments company's stock valued at $3,557,000 after acquiring an additional 28,195 shares during the last quarter. Hsbc Holdings PLC purchased a new position in shares of Cognex during the 4th quarter worth approximately $477,000. Finally, Nebula Research & Development LLC purchased a new position in shares of Cognex during the 4th quarter worth approximately $453,000. 88.12% of the stock is owned by hedge funds and other institutional investors.

Cognex Price Performance

NASDAQ CGNX opened at $44.25 on Thursday. Cognex Corporation has a 1-year low of $22.67 and a 1-year high of $45.03. The company has a market capitalization of $7.43 billion, a P/E ratio of 62.32 and a beta of 1.47. The business has a 50 day moving average price of $36.68 and a 200 day moving average price of $32.25.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The firm had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. During the same period last year, the business posted $0.23 EPS. Cognex's quarterly revenue was up 4.2% on a year-over-year basis. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, research analysts expect that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Thursday, August 14th will be paid a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Thursday, August 14th. Cognex's dividend payout ratio (DPR) is presently 45.07%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CGNX. Robert W. Baird increased their target price on Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research note on Monday, June 16th. The Goldman Sachs Group increased their target price on Cognex from $29.00 to $32.00 and gave the stock a "sell" rating in a research note on Thursday, June 12th. Needham & Company LLC increased their target price on Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Melius raised Cognex from a "hold" rating to a "buy" rating and set a $60.00 target price for the company in a research note on Thursday, July 10th. Finally, DA Davidson increased their target price on Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $42.31.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.